cysteine has been researched along with Carcinoma 256, Walker in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (87.50) | 18.7374 |
| 1990's | 1 (12.50) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| ACTON, EM; BAKER, BR; GOODMAN, L; IWAMOTO, RH; ROSS, LO; SKINNER, WA | 1 |
| Gurtoo, HL; Hipkens, JH; Sharma, SD | 1 |
| Gübitz, G; Tillian, M; Wintersteiger, R | 1 |
| Hall, IH; Lee, KH; Mar, EC; Starnes, CO; Waddell, TG | 1 |
| Kronrád, L; Petrboková, I; Vavrejn, B | 1 |
| Connors, TA; Mandel, HG; Melzack, DH | 1 |
| Elson, LA | 1 |
| Connors, TA; Jenney, A; Whisson, ME | 1 |
8 other study(ies) available for cysteine and Carcinoma 256, Walker
| Article | Year |
|---|---|
POTENTIAL ANTICANCER AGENTS. LXXIX. AROMATIC NITROGEN MUSTARDS DERIVED FROM CYSTEINE.
Topics: Antineoplastic Agents; Carcinoma; Carcinoma 256, Walker; Chemistry, Pharmaceutical; Cysteine; Mechlorethamine; Nitrogen Mustard Compounds; Pharmacology; Rats; Research | 1963 |
Role of glutathione in the metabolism-dependent toxicity and chemotherapy of cyclophosphamide.
Topics: Acrolein; Alanine; Animals; Body Weight; Carcinoma 256, Walker; Cyclophosphamide; Cysteine; Female; Glutathione; Hematuria; Infusions, Parenteral; Liver; Male; Mice; Rats; Time Factors | 1981 |
Systemic application of cysteine-2:1-crotonal adduct for pharmacokinetic studies of tumor models in rats and mice.
Topics: Animals; Antineoplastic Agents; Ascitic Fluid; Carcinoma 256, Walker; Carcinoma, Ehrlich Tumor; Cysteine; Cytoplasm; Dansyl Compounds; Hydrazines; Mice; Neoplasms, Experimental; Rats; Rats, Sprague-Dawley | 1996 |
Antitumor agents. 21. A proposed mechanism for inhibition of cancer growth by tenulin and helenalin and related cyclopentenones.
Topics: Animals; Antineoplastic Agents, Phytogenic; Ascitic Fluid; Carcinoma 256, Walker; Carcinoma, Ehrlich Tumor; Chromatin; Cyclopentanes; Cysteine; DNA, Neoplasm; Glutathione; Histidine; Lactones; Leukemia, Experimental; Leukemia, Lymphoid; Male; Mice; Mice, Inbred DBA; Neoplasm Proteins; Rats; Sesquiterpenes; Sesquiterpenes, Guaiane; Spectrophotometry, Ultraviolet; Time Factors | 1977 |
Possibilities of scintigraphic detection of tumours and damaged tissues with the aid of radioactive mercury compounds.
Topics: Animals; Carcinoma 256, Walker; Carcinosarcoma; Cysteine; Dogs; Male; Mercury Isotopes; Mice; Myocardial Infarction; Neoplasms, Experimental; Radionuclide Imaging; Rats; Sarcoma, Yoshida | 1972 |
Studies on the reversal of the selective antitumour effect of the aziridinyl derivative CB 1954 by 4-amino-5-imidazolecarboxamide.
Topics: Adenosine; Amides; Amines; Animals; Azirines; Benzoates; Carcinoma 256, Walker; Chromatography, Thin Layer; Cysteine; Guanosine; Imidazoles; Inosine; Leucine; Male; Nitro Compounds; ortho-Aminobenzoates; Purines; Pyrimidines; Rats; Thymidine; Time Factors; Tritium; Uridine | 1972 |
Growth inhibitory and haematological effects of alkylating agents and attempts at their modification to give greater selectivity of anti-tumour action.
Topics: Alkylating Agents; Animals; Body Weight; Carcinoma 256, Walker; Chemical Phenomena; Chemistry; Chlorambucil; Cysteine; Hematopoiesis; Mechlorethamine; Mice; Mitosis; Neoplasms, Experimental; Rats | 1968 |
Reduction of the toxicity of radiomimetic alkylating agents in rats by thiol pretreatment. V. The effect of thiol pretreatment on the anti-tumour action of Merophan.
Topics: Animals; beta-Aminoethyl Isothiourea; Carcinoma 256, Walker; Cysteine; Mice; Neoplasms, Experimental; Nitrogen Mustard Compounds; Plasmacytoma | 1965 |